76 related articles for article (PubMed ID: 12824528)
1. Methods to study p53-repressed promoters.
Dumont P; Della Pietra A; Murphy ME
Methods Mol Biol; 2003; 234():111-20. PubMed ID: 12824528
[TBL] [Abstract][Full Text] [Related]
2. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
Kühnel F; Zender L; Wirth T; Schulte B; Trautwein C; Manns M; Kubicka S
Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724
[TBL] [Abstract][Full Text] [Related]
4. [Chromatin immunoprecipitation and its preliminary application for gene regulation].
Zhang Y; Cheng XK; Wu NH; Shen YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):52-5. PubMed ID: 15052775
[TBL] [Abstract][Full Text] [Related]
5. LMO3 interacts with p53 and inhibits its transcriptional activity.
Larsen S; Yokochi T; Isogai E; Nakamura Y; Ozaki T; Nakagawara A
Biochem Biophys Res Commun; 2010 Feb; 392(3):252-7. PubMed ID: 19995558
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system.
Takada S; Kaneniwa N; Tsuchida N; Koike K
Virology; 1996 Feb; 216(1):80-9. PubMed ID: 8615009
[TBL] [Abstract][Full Text] [Related]
7. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
8. NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.
Hublitz P; Kunowska N; Mayer UP; Müller JM; Heyne K; Yin N; Fritzsche C; Poli C; Miguet L; Schupp IW; van Grunsven LA; Potiers N; van Dorsselaer A; Metzger E; Roemer K; Schüle R
Genes Dev; 2005 Dec; 19(23):2912-24. PubMed ID: 16322561
[TBL] [Abstract][Full Text] [Related]
9. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
10. Transactivation and transrepression studies with p53.
Scian MJ; Frum R; Deb SP; Deb S
Methods Mol Biol; 2003; 234():93-110. PubMed ID: 12824527
[TBL] [Abstract][Full Text] [Related]
11. Comparative binding of p53 to its promoter and DNA recognition elements.
Weinberg RL; Veprintsev DB; Bycroft M; Fersht AR
J Mol Biol; 2005 May; 348(3):589-96. PubMed ID: 15826656
[TBL] [Abstract][Full Text] [Related]
12. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
Thomas S; Reisman D
Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
[TBL] [Abstract][Full Text] [Related]
14. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
[TBL] [Abstract][Full Text] [Related]
15. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
16. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the p53 transcriptional activity.
Liu G; Chen X
J Cell Biochem; 2006 Feb; 97(3):448-58. PubMed ID: 16288459
[TBL] [Abstract][Full Text] [Related]
18. HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.
Hsu CH; Chang MD; Tai KY; Yang YT; Wang PS; Chen CJ; Wang YH; Lee SC; Wu CW; Juan LJ
EMBO J; 2004 Jun; 23(11):2269-80. PubMed ID: 15141169
[TBL] [Abstract][Full Text] [Related]
19. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
20. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
